| Literature DB >> 25095872 |
Ángel Guevara1, Juan Moreira, Hipatia Criollo, Sandra Vivero, Marcia Racines, Varsovia Cevallos, Rosanna Prandi, Cynthia Caicedo, Francisco Robinzon, Mariella Anselmi.
Abstract
Chagas disease was described in Ecuador in 1930 in the province of Guayas and thereafter in various provinces. Triatomine were reported in the province of Esmeraldas but no human infection has been described. Here we report the first evidence that the disease does exist in the province of Esmeraldas. In indigenous Awá communities located in the northwest jungle of the Esmeraldas province, 144 individuals were tested using ELISA and PCR for T.cruzi of which 5 (3.47%) were positive. Twenty eight triatomine were collected, 27 were Triatoma dispar and 1 Pastrongylus rufotuberculatus, T.cruzi was detected in 11 (42.3%) of 26 insects.Entities:
Mesh:
Year: 2014 PMID: 25095872 PMCID: PMC4131061 DOI: 10.1186/1756-3305-7-358
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Triatomine insects collected in Awá’s communities of northwest jungle of Esmeraldas province, Ecuador
| Community | No | Species | Habitat |
|---|---|---|---|
| Pambilar | 17 |
| Peridomestic |
| Balsareño | 10 |
| Domestic |
| Balsareño | 1 |
| Domestic |
Figure 1Agarose gel showing PCR products 330 bp amplified with specific primers Tc121 y Tc122. M: DNA molecular markers. Lane 1 – 4 samples from Triatoma dispar L. Lane 5 negative control. Lane 6 positive control.
Results expressed in absorbance values from human sera samples with three different ELISA tests
| Sample code | Age | Gender | Biokit (ELISA)® | Bioschile (ELISA)® | Chagatest (ELISA)® |
|---|---|---|---|---|---|
| Pamb 10 | 21 | Male | 1.82 | 1.50 | 0.62 |
| Pamb 12 | 29 | Female | > 2.0 | > 2.0 | 2.0 |
| Pamb 18 | 48 | Female | > 2.0 | > 2.0 | > 2.0 |
| Pamb 59 | 62 | Male | 1.84 | 1.96 | 2.0 |
| Bals 37 | 32 | Male | > 2.0 | > 2.0 | > 2.0 |
Cut-off value: Biokit negative <0.9; Bioschile negative < 0.9; Chagatest negative < 0.230.
Figure 2Agarose gel showing PCR products 330 bp amplified with specific primers Tc121 y Tc122. M: DNA molecular markers. Lane 1 – 5 blood samples from Awá infected people. Lane 6 negative control. Lane 7 positive control.